These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 11302946)

  • 1. Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration.
    Tessier B; Moine L; Peramo A; Tsapis N; Fattal E
    Drug Deliv Transl Res; 2024 Aug; 14(8):2062-2078. PubMed ID: 38517568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response.
    Shen H; Zhao X; Xu L
    Heliyon; 2023 Nov; 9(11):e21105. PubMed ID: 37954384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.
    Ryrfeldt A; Andersson P; Edsbäcker S; Tönnesson M; Davies D; Pauwels R
    Eur J Respir Dis Suppl; 1982; 122():86-95. PubMed ID: 6958498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects.
    Edsbäcker S; Andersson P; Lindberg C; Paulson J; Ryrfeldt A; Thalén A
    Drug Metab Dispos; 1987; 15(3):403-11. PubMed ID: 2886319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver.
    Jönsson G; Aström A; Andersson P
    Drug Metab Dispos; 1995 Jan; 23(1):137-42. PubMed ID: 7720517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant plus budesonide decreases lung and systemic responses to injurious ventilation in preterm sheep.
    Hillman NH; Kothe TB; Schmidt AF; Kemp MW; Royse E; Fee E; Salomone F; Clarke MW; Musk GC; Jobe AH
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L41-L48. PubMed ID: 31617728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes.
    Borghardt JM; Kloft C; Sharma A
    Can Respir J; 2018; 2018():2732017. PubMed ID: 30018677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of budesonide and surfactant in preterm fetal sheep.
    Kothe TB; Royse E; Kemp MW; Schmidt A; Salomone F; Saito M; Usuda H; Watanabe S; Musk GC; Jobe AH; Hillman NH
    Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L193-L201. PubMed ID: 29671605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.
    Naikwade SR; Bajaj AN; Gurav P; Gatne MM; Singh Soni P
    AAPS PharmSciTech; 2009; 10(3):993-1012. PubMed ID: 19649711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of the in vivo esterification of budesonide in human airways.
    van den Brink KI; Boorsma M; Staal-van den Brekel AJ; Edsbäcker S; Wouters EF; Thorsson L
    Br J Clin Pharmacol; 2008 Jul; 66(1):27-35. PubMed ID: 18384442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.
    Kuna P; Peters MJ; Manjra AI; Jorup C; Naya IP; Martínez-Jimenez NE; Buhl R
    Int J Clin Pract; 2007 May; 61(5):725-36. PubMed ID: 17362472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy.
    Sakagami M; Byron PR
    Clin Pharmacokinet; 2005; 44(3):263-77. PubMed ID: 15762769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat.
    Jendbro M; Johansson CJ; Strandberg P; Falk-Nilsson H; Edsbäcker S
    Drug Metab Dispos; 2001 May; 29(5):769-76. PubMed ID: 11302946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue.
    Miller-Larsson A; Mattsson H; Hjertberg E; Dahlbäck M; Tunek A; Brattsand R
    Drug Metab Dispos; 1998 Jul; 26(7):623-30. PubMed ID: 9660844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data.
    Edsbäcker S; Brattsand R
    Ann Allergy Asthma Immunol; 2002 Jun; 88(6):609-16. PubMed ID: 12086369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of butixocort 21-propionate, budesonide, and beclomethasone dipropionate in the rat after intratracheal, intravenous, and oral treatments.
    Chanoine F; Grenot C; Heidmann P; Junien JL
    Drug Metab Dispos; 1991; 19(2):546-53. PubMed ID: 1676668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.
    Miller-Larsson A; Jansson P; Runström A; Brattsand R
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1455-61. PubMed ID: 11029361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity.
    Brattsand R; Miller-Larsson A
    Clin Ther; 2003; 25 Suppl C():C28-41. PubMed ID: 14642802
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.